These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33772783)

  • 1. Pathogenic MAPT mutations Q336H and Q336R have isoform-dependent differences in aggregation propensity and microtubule dysfunction.
    Xia Y; Nasif L; Giasson BI
    J Neurochem; 2021 Jul; 158(2):455-466. PubMed ID: 33772783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.
    Xia Y; Sorrentino ZA; Kim JD; Strang KH; Riffe CJ; Giasson BI
    J Biol Chem; 2019 Nov; 294(48):18488-18503. PubMed ID: 31653695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.
    Tacik P; DeTure M; Hinkle KM; Lin WL; Sanchez-Contreras M; Carlomagno Y; Pedraza O; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
    J Neuropathol Exp Neurol; 2015 Nov; 74(11):1042-52. PubMed ID: 26426266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene.
    Pickering-Brown SM; Baker M; Nonaka T; Ikeda K; Sharma S; Mackenzie J; Simpson SA; Moore JW; Snowden JS; de Silva R; Revesz T; Hasegawa M; Hutton M; Mann DM
    Brain; 2004 Jun; 127(Pt 6):1415-26. PubMed ID: 15047590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Tau Proteoforms in Health and Disease.
    Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S
    Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPT mutations, tauopathy, and mechanisms of neurodegeneration.
    Strang KH; Golde TE; Giasson BI
    Lab Invest; 2019 Jul; 99(7):912-928. PubMed ID: 30742061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau mutation S356T in the three repeat isoform leads to microtubule dysfunction and promotes prion-like seeded aggregation.
    Xia Y; Bell BM; Kim JD; Giasson BI
    Front Neurosci; 2023; 17():1181804. PubMed ID: 37304025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy.
    Hogg M; Grujic ZM; Baker M; Demirci S; Guillozet AL; Sweet AP; Herzog LL; Weintraub S; Mesulam MM; LaPointe NE; Gamblin TC; Berry RW; Binder LI; de Silva R; Lees A; Espinoza M; Davies P; Grover A; Sahara N; Ishizawa T; Dickson D; Yen SH; Hutton M; Bigio EH
    Acta Neuropathol; 2003 Oct; 106(4):323-36. PubMed ID: 12883828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Q336H MAPT Mutation Linked to Pick's Disease Leads to Increased Binding of Tau to the Microtubule Network
    Siano G; Micaelli M; Scarlatti A; Quercioli V; Di Primio C; Cattaneo A
    Front Mol Neurosci; 2020; 13():569395. PubMed ID: 33343296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The genetics of dementias. Part 1: Molecular basis of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)].
    Kowalska A
    Postepy Hig Med Dosw (Online); 2009 Jun; 63():278-86. PubMed ID: 19535823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct differences in prion-like seeding and aggregation between Tau protein variants provide mechanistic insights into tauopathies.
    Strang KH; Croft CL; Sorrentino ZA; Chakrabarty P; Golde TE; Giasson BI
    J Biol Chem; 2018 Feb; 293(7):2408-2421. PubMed ID: 29259137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tauopathies as clinicopathological entities.
    Irwin DJ
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S29-33. PubMed ID: 26382841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau isoform-specific stabilization of intermediate states during microtubule assembly and disassembly.
    Best RL; LaPointe NE; Liang J; Ruan K; Shade MF; Wilson L; Feinstein SC
    J Biol Chem; 2019 Aug; 294(33):12265-12280. PubMed ID: 31266806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function.
    Iyer A; Lapointe NE; Zielke K; Berdynski M; Guzman E; Barczak A; Chodakowska-Żebrowska M; Barcikowska M; Feinstein S; Zekanowski C
    PLoS One; 2013; 8(9):e76409. PubMed ID: 24086739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tau alternative splicing in familial and sporadic tauopathies.
    Niblock M; Gallo JM
    Biochem Soc Trans; 2012 Aug; 40(4):677-80. PubMed ID: 22817715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAPT Q336H mutation: Intrafamilial phenotypic heterogeneity in a new Italian family.
    Villa C; Rossi G; Bizzozero I; Prioni S; Boiocchi C; Agosta F; Canu E; Filippi M; Giaccone G; Caroppo P
    Eur J Neurol; 2022 May; 29(5):1529-1533. PubMed ID: 35020237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross-seeding ability.
    Bhopatkar AA; Bhatt N; Haque MA; Xavier R; Fung L; Jerez C; Kayed R
    Protein Sci; 2024 Sep; 33(9):e5099. PubMed ID: 39145409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum.
    Gossye H; Van Mossevelde S; Sieben A; Bjerke M; Hendrickx Van de Craen E; van der Zee J; De Deyn PP; De Bleecker J; Versijpt J; van den Ende J; Deryck O; Bourgeois P; Bier JC; Goethals M; Vandenberghe R; Engelborghs S; Van Broeckhoven C
    Brain; 2023 Apr; 146(4):1624-1636. PubMed ID: 36171642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.